Clinical trials
Merosin Deficient CMD (Full or Partial) clinical trials
Below are recruiting merosin deficient cmd (full or partial) clinical trials, each written for real people, not researchers. We’re tracking 236 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06293521RecruitingPhase 2
Nerve treatment options for deep cavities in baby teeth
This study compares two ways to treat severe cavities in baby teeth: removing only the infected part of the nerve (pulpotomy) versus removing all the nerve tissue (pulpectomy). It looks at which method helps the tooth heal better and stay healthy longer.
CairoAges 4–6 - NCT06185205RecruitingPhase 2
Accelerated high-dose radiation for early breast cancer
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
Richmond, VirginiaAges 45–79 - NCT06195891RecruitingPhase 1
Orca-T stem cell transplant for older adults with blood cancer
This study tests a new way to give donor stem cells (called Orca-T) after a special type of chemotherapy and radiation. It is for people aged 60–75 with certain blood cancers that have not responded well to standard treatments.
Duarte, CaliforniaAges 60 years+ - NCT06175000RecruitingPhase 2
Maintenance obinutuzumab for central nervous system lymphoma
This trial tests whether a maintenance drug called obinutuzumab can help prevent relapse in people with primary central nervous system lymphoma (a rare lymphoma in the brain or spine) who have already responded to initial chemotherapy. It is for those who have achieved at least a partial or complete response to their first treatment.
New York, New YorkAges 18 years+ - NCT06129747RecruitingPhase 2
Repeat Lumpectomy and Daily Partial Breast Radiation for Cancer Return
This trial studies a second breast-conserving surgery followed by daily radiation to just the tumor area for people whose breast cancer has returned in the same breast. It aims to see if this approach is safe and effective, potentially avoiding a mastectomy.
Cleveland, OhioAges 19 years+ - NCT06121219Recruiting
Can visual retraining after stroke improve sight?
This trial tests whether special computer-based visual exercises can help people whose vision was damaged by a stroke. You would do the exercises at home for several months.
Rochester, New YorkAges 21–80 - NCT06070376Recruiting
Comparing two stents for esophageal cancer swallowing problems
This study compares two types of stents (metal tubes) placed in the esophagus to help people with advanced esophageal cancer swallow more easily. Both stents are designed to keep the esophagus open and improve quality of life.
São Paulo, São PauloAges 18 years+ - NCT06047717Recruiting
Virtual reality navigation study for stroke survivors
This study uses virtual reality to understand how vision loss from a stroke affects navigation. You may help researchers learn more by wearing a VR headset and doing simple tasks.
Rochester, New YorkAges 21–75 - NCT05424354RecruitingPhase 4
Test powder dressing vs usual care for recent burn wounds
This study compares a transforming powder dressing to the standard dressing for partial-thickness burn wounds. It aims to see whether the powder dressing helps wounds heal better and safely when used soon after the burn.
Orange, CaliforniaAges 18–65 - NCT05996536Recruiting
Fat labeling study in familial partial lipodystrophy
This study tests a safe way to label fat (triglycerides) in people with a rare condition called familial partial lipodystrophy (FPL), where fat is missing in some areas. It involves two small fat biopsies, one from the belly and one from the thigh, to understand how the body handles fat.
Bethesda, MarylandAges 18–65 - NCT05868408Recruiting
Whey formula for healthy full-term infants – growth and comfort
This study tests whether a special partially-digested whey formula is as good as standard formula for healthy full-term babies. It looks at how babies grow and how well they tolerate the formula.
Cavite CityAges birth–4 weeks - NCT05842044RecruitingPhase 2
NSAID pain medicine after robotic kidney-sparing surgery
This Phase 2 study looks at whether taking an anti-inflammatory pain medicine (an NSAID) after robotic partial nephrectomy is safe and helpful. It may reduce pain while checking for stomach, bleeding, and heart-related side effects after kidney-sparing surgery.
Miami, FloridaAges 18–99 - NCT05800457Recruiting
Test synovectomy to reduce pain after knee replacement
This study looks at whether a procedure called synovectomy (removing inflamed joint lining) can reduce pain after a first knee replacement on one side. It focuses on people with clear signs of inflammation on ultrasound and checks follow-up outcomes after surgery.
London, OntarioAges 41–80 - NCT03865771Recruiting
Sleep study to improve memory in children with focal epilepsy
This study looks at how sleep affects memory in children with certain types of age-related focal epilepsy. It compares them to children hospitalized for non-nerve (non-neurologic) reasons to see whether sleep-related brain patterns relate to learning and memory.
NancyAges 6–13 - NCT05706155Recruiting
Switching some animal protein to plant protein for Type 2 diabetes
This study tests whether replacing part of your animal protein with plant-based protein can improve Type 2 diabetes control. It may help your blood sugar and weight management without changing everything about your diet.
Porto Alegre, Rio Grande do SulAges 18–65 - NCT05653622RecruitingPhase 2
FDOPA PET–guided radiation planning for glioblastoma patients
This Phase 2 trial tests a radiation “planning” approach guided by an FDOPA PET scan. It aims to better target glioblastoma tissue in people who can’t follow the standard STUPP treatment plan.
Nancy, DeAges 18 years+ - NCT05616884Enrolling by invitation
Cemented vs cementless partial knee replacement study
This study compares two ways of fixing a partial knee replacement: cemented or cementless. It may help doctors learn which method works better for patients with certain types of knee bone.
Alexandria, VirginiaAges 18–85 - NCT05592938Recruiting
Partial breast re-irradiation for cancer recurrence
This trial tests a shorter course of radiation to only the part of the breast where cancer has come back. It's for women who had radiation years ago and now have a small new or recurrent tumor that can be removed by surgery.
New York, New YorkAges 18–99 - NCT05470504RecruitingPhase 2
Pegvisomant for severe insulin resistance from rare fat or gene problems
This Phase 2 study tests pegvisomant, a medicine that blocks growth hormone, to see if it can improve severe insulin resistance in people with a specific genetic cause or a rare fat distribution condition. If you fit the rare diagnosis, the study may help clarify whether growth-hormone blocking can improve blood sugar and related health markers.
Bethesda, MarylandAges 18–70 - NCT05444465Recruiting
Implant test for severe partial rotator cuff shoulder tears
This study tests whether a specific implant (the REGENETEN bioinductive implant) helps heal severe partial-thickness rotator cuff tears in the shoulder. You might benefit if you have a high-grade tear that didn’t improve after months of physical therapy.
Rome, GeorgiaAges 18 years+ - NCT05439850RecruitingPhase 4
Bioinductive patch for severe torn shoulder tendons
This trial studies a special patch placed during minimally invasive shoulder surgery to help heal full-thickness rotator cuff tears. It may help people whose tears are large or massive and who already tried non-surgical treatment without enough improvement.
Detroit, MichiganAges 18 years+ - NCT05350722Recruiting
Single pre-surgery radiation for low-risk breast cancer
This trial tests a single, shorter course of radiation given before breast surgery for people with low-risk, hormone-receptor–positive breast cancer. It may help treat the breast tumor while reducing the number and length of radiation treatments.
SydneyAges 40 years+ - NCT05290818Recruiting
Robotic vs standard knee replacement for inner-joint wear
This trial compares robotic-assisted knee replacement with the usual (non-robotic) approach for people with severe arthritis on the inner (medial) side of the knee. It aims to see which method works better for pain and function while matching the right knee anatomy for certain implant types.
Edinburgh, LothianAges 50–75 - NCT05231798RecruitingPhase 2
PET and brain scans in adults with Down syndrome
This study looks at how well a brain chemical system works in adults with Down syndrome as they age, including how it relates to Alzheimer’s-type brain changes and thinking skills. It uses brain scans and memory/thinking tests to see whether these measures can help track risk or changes over time.
Nashville, TennesseeAges 18–55
Hear when a new Merosin Deficient CMD (Full or Partial) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for merosin deficient cmd (full or partial)?
- Yes. Clin2 currently lists 236 recruiting merosin deficient cmd (full or partial) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a merosin deficient cmd (full or partial) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a merosin deficient cmd (full or partial) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.